Holding(s) in Company

1 Feb 2005 12:45

ReGen Therapeutics PLC01 February 2005 ReGen Therapeutics Plc SUBSTANTIAL SHAREHOLDING 1 February, 2005 ReGen Therapeutics Plc (the "Company") announces that on 31 January 2005 itreceived notification from Mr P. Garrod that he is beneficially interested in36,000,000 ordinary shares of the Company representing 10.5% of the currentissued share capital of the Company. For further information, please contact: Andrew MarshallMarshall Robinson RoeTel. 020 7960 6007 This information is provided by RNS The company news service from the London Stock Exchange